You have read all your free articles, to continue reading subscribe to read the rest of this content.
Karolinska Development and Karolinska Institutet Holding AB, a company wholly owned by Karolinska Institutet (KI) have signed a new non-exclusive deal flow agreement. This agreement is a key element of a new strategy designed to improve the translation of medical innovations originating from KI iAlready a subscriber Login You have…
AstraZeneca has entered into a new global development and commercialization agreement with Daiichi Sankyo Company, for DS-1062, Daiichi Sankyo’s trophoblast cell-surface antigen 2 (TROP2)-directed antibody drug conjugate (ADC) and potential new medicine for the treatment of multiple tumour types. Already a subscriber Login You have read all your free articles,…
AstraZeneca and MedImmune announce the expansion of their clinical collaboration with Incyte Corporation. As part of the agreement, the companies will evaluate the efficacy and safety of epacadostat, Incyte’s investigational selective IDO1 enzyme inhibitor, in combination with AstraZeneca’s Already a subscriber Login You have read all your free articles, to continue…
At RSNA, the global radiology show in Chicago, Sectra is launching an enhanced model of its 55’’ visualization table featuring new touch technology. The table enables medical staff and students to navigate much more quickly and smoothly when working with 3D images of actual patient cases, theAlready a subscriber Login…
